| Company Name: |
Wuhan Chemstan Biotechnology Co., Ltd. Gold
|
| Tel: |
027-65317797 15926423062 |
| Email: |
422450190@qq.com |
| Products Intro: |
Product Name:Urelumab
Purity:>95%;1mg/ml Package:200ug;500ug;1mg
|
| Company Name: |
ShangHai Biochempartner Co.,Ltd
|
| Tel: |
177-54423994 17754423994 |
| Email: |
2853530910@QQ.com |
| Products Intro: |
Product Name:Urelumab
CAS:934823-49-1
Purity:95% Package:100ug;500ug;1mg
|
Urelumab manufacturers
- Urelumab
-
- $528.00 / 1mg
-
2024-10-24
- CAS:934823-49-1
- Min. Order:
- Purity: SDS-PAGE:97.4%;SEC-HPLC:97.7%
- Supply Ability: 10g
|
| | Urelumab Basic information |
| Product Name: | Urelumab | | Synonyms: | Urelumab;Research Grade Urelumab(DHG11002);BMS-663513;Urelumab (anti-TNFRSF9);BMS-663513|||BMS-66513;anti-4-1BB antibody | | CAS: | 934823-49-1 | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![Urelumab Structure]() |
| | Urelumab Chemical Properties |
| form | Liquid | | color | Colorless to light yellow |
| | Urelumab Usage And Synthesis |
| Biological Activity | Urelumab has been used in trials studying the treatment of Leukemia, Multiple Myeloma, Malignant Tumors, and Cancer - Solid Tumors and B-Cell Non-Hodgkin's Lymphoma. Urelumab is a fully human antibody that targets CD137. The antibody product was developed using Medarex's UltiMAb(R) technology and was the first UltiMAb- derived antibody in clinical development by Bristol-Myers Squibb under the December 2003 agreement with Medarex. | | target | 4-1BB |
| | Urelumab Preparation Products And Raw materials |
|